Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil
Authors:
- Elena N PugachevaEPElena N Pugacheva
- Alexey V IvanovAIAlexey V Ivanov
- Julia E KravchenkoJKJulia E Kravchenko
- Boris P KopninBoris P Kopnin
- Arnold J LevineALArnold J Levine
- Peter M ChumakovPCPeter M Chumakov
- 5 July 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (30) , 4595-4600
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 30 references indexed in Scilit:
- The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosisOncogene, 2001
- Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutantsOncogene, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Mutant p53 protein expression interferes with p53-independent apoptotic pathwaysOncogene, 1998
- `Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domainOncogene, 1998
- Regulation ofp53downstream genesSeminars in Cancer Biology, 1998
- Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytesOncogene, 1997
- The Spectrum of Mutations at the p53 LocusAnnals of the New York Academy of Sciences, 1995
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts.Genes & Development, 1991